The Vivid E9 Breakthrough 2012 includes a 4-D transducer for transesophageal echocardiography, as well as workflow tools.
GE Healthcare’s latest Vivid E9 cardiovascular ultrasound has received FDA clearance, the company announced.
The Vivid E9 Breakthrough 2012 includes a 4-D transducer for transesophageal echocardiography (TEE), as well as tools for workflow efficiencies.
The 4-D TEE transducer allows the system to be used more often in settings beyond the echo lab, the company said. Clinicians can view precise images of the heart during assessment and diagnosis in the echo lab, as well as support procedures in the operating room and cath lab. The system can now be used for procedures such as mitral valve repair, transcatheter aortic valve repair, atrial septal defect closures and patent foraman ovale closures.
The Vivid E9 BT12 also includes several new cardiovascular ultrasound features aimed at improving 4-D imaging and workflow, such as a new tilt and rotate function. Vivid E9 BT12 is also CE Marked and available for sale across Europe and many countries around the world.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Finds Transvaginal Ultrasound Unreliable for Detecting Endometrial Cancer in Black Patients
July 3rd 2024Utilizing a threshold of less than 5 mm of ultrasound-measured endometrial thickness, the authors of a new study noted an 11.4 percent false-negative probability for endometrial cancer in Black patients.
New Study Shows Non-Radiologists Interpreting 28 Percent of Imaging for Medicare Patients
June 28th 2024While radiologists interpreted approximately 99 percent of all non-cardiac CT, MRI and nuclear medicine studies in hospital and emergency department settings for Medicare beneficiaries, new research shows significantly less radiologist review of cardiac imaging and office-based imaging.
FDA Clears Pocket-Sized ECG System and AI Technology for Detection of Cardiac Conditions
June 27th 2024Using a reduced leadset and deep neural network algorithms trained on more than 175 million electrocardiograms, the KAI 12L technology reportedly detects up to 35 cardiac determinations, including acute myocardial infarction.